PL2790695T3 - Kompozycja farmaceutyczna zawierająca (S)-2-(2-oksopirolidyn-1-ylo)butanamid - Google Patents
Kompozycja farmaceutyczna zawierająca (S)-2-(2-oksopirolidyn-1-ylo)butanamidInfo
- Publication number
- PL2790695T3 PL2790695T3 PL12798303T PL12798303T PL2790695T3 PL 2790695 T3 PL2790695 T3 PL 2790695T3 PL 12798303 T PL12798303 T PL 12798303T PL 12798303 T PL12798303 T PL 12798303T PL 2790695 T3 PL2790695 T3 PL 2790695T3
- Authority
- PL
- Poland
- Prior art keywords
- butanamid
- oxopyrrolidin
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- HPHUVLMMVZITSG-LURJTMIESA-N levetiracetam Chemical compound CC[C@@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-LURJTMIESA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11009922 | 2011-12-16 | ||
| PCT/EP2012/074931 WO2013087563A1 (en) | 2011-12-16 | 2012-12-10 | Pharmaceutical composition comprising (s)-2-(2-oxopyrrolidin-1-yl)butanamid |
| EP12798303.9A EP2790695B1 (en) | 2011-12-16 | 2012-12-10 | Pharmaceutical composition comprising (s)-2-(2-oxopyrrolidin-1-yl)butanamid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2790695T3 true PL2790695T3 (pl) | 2016-07-29 |
Family
ID=47324162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12798303T PL2790695T3 (pl) | 2011-12-16 | 2012-12-10 | Kompozycja farmaceutyczna zawierająca (S)-2-(2-oksopirolidyn-1-ylo)butanamid |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2790695B1 (pl) |
| CY (1) | CY1117398T1 (pl) |
| DK (1) | DK2790695T3 (pl) |
| ES (1) | ES2568075T3 (pl) |
| HR (1) | HRP20160278T1 (pl) |
| HU (1) | HUE026791T2 (pl) |
| PL (1) | PL2790695T3 (pl) |
| RS (1) | RS54692B1 (pl) |
| SI (1) | SI2790695T1 (pl) |
| SM (1) | SMT201600096B (pl) |
| WO (1) | WO2013087563A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116459225B (zh) * | 2023-04-26 | 2023-11-10 | 东莞市金美济药业有限公司 | 一种艾拉戈克钠片及其制备工艺 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2709521A1 (en) * | 2007-12-21 | 2009-07-16 | Alembic Limited | Novel coated extended release pharmaceutical compositions of levetiracetam |
| DK2273975T3 (da) | 2008-03-03 | 2014-06-30 | Ucb Pharma Sa | Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser |
| JP2010024156A (ja) | 2008-07-16 | 2010-02-04 | Ucb Pharma Sa | レベチラセタムを含む医薬組成物 |
| US20100172979A1 (en) | 2008-12-24 | 2010-07-08 | Zhongshui Yu | Controlled-release formulations |
| WO2011136751A2 (en) | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Water soluble pharmaceutical composition |
-
2012
- 2012-12-10 HR HRP20160278TT patent/HRP20160278T1/hr unknown
- 2012-12-10 WO PCT/EP2012/074931 patent/WO2013087563A1/en not_active Ceased
- 2012-12-10 RS RS20160212A patent/RS54692B1/sr unknown
- 2012-12-10 ES ES12798303.9T patent/ES2568075T3/es active Active
- 2012-12-10 DK DK12798303.9T patent/DK2790695T3/en active
- 2012-12-10 EP EP12798303.9A patent/EP2790695B1/en active Active
- 2012-12-10 HU HUE12798303A patent/HUE026791T2/en unknown
- 2012-12-10 SI SI201230509A patent/SI2790695T1/sl unknown
- 2012-12-10 PL PL12798303T patent/PL2790695T3/pl unknown
-
2016
- 2016-04-05 SM SM201600096T patent/SMT201600096B/it unknown
- 2016-04-06 CY CY20161100278T patent/CY1117398T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2790695T3 (en) | 2016-04-18 |
| SMT201600096B (it) | 2016-07-01 |
| SI2790695T1 (sl) | 2016-09-30 |
| EP2790695B1 (en) | 2016-03-16 |
| EP2790695A1 (en) | 2014-10-22 |
| RS54692B1 (sr) | 2016-08-31 |
| HUE026791T2 (en) | 2016-07-28 |
| CY1117398T1 (el) | 2017-04-26 |
| WO2013087563A1 (en) | 2013-06-20 |
| ES2568075T3 (es) | 2016-04-27 |
| HRP20160278T1 (hr) | 2016-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3864A (en) | Pharmaceutical composition | |
| GB201113662D0 (en) | Pharmaceutical compositions | |
| AP3656A (en) | Pharmaceutical compositions | |
| GB201118232D0 (en) | Pharmaceutical composition | |
| ZA201308208B (en) | Pharmaceutical compositions | |
| ZA201501930B (en) | Pharmaceutical composition | |
| SG11201400580VA (en) | Pharmaceutical composition for inhalation | |
| SG11201503807TA (en) | Pharmaceutical compositions | |
| IL232305A0 (en) | pharmaceutical preparations | |
| EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
| ZA201308157B (en) | Pharmaceutical composition | |
| ZA201308152B (en) | Pharmaceutical antiretroviral composition | |
| EP2727593A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL | |
| GB201118181D0 (en) | Pharmaceutical compositions | |
| EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
| PL2709599T3 (pl) | Kompozycja farmaceutyczna zawierająca drotawerynę | |
| ZA201502987B (en) | Pharmaceutical composition | |
| HUP1100444A2 (en) | Pharmaceutical composition | |
| ZA201308414B (en) | Solid pharmaceutical composition | |
| HUP1100445A2 (en) | Pharmaceutical composition | |
| SI2790695T1 (sl) | Farmacevtska sestava (s)-2-(2-oksopirolidin-1-il) butanamid | |
| ZA201309537B (en) | Pharmaceutical composition comprising fexofedine | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| ZA201400751B (en) | Pharmaceutical composition | |
| GB201207628D0 (en) | New pharmaceutical composition |